Mobocertinib in platinum-pretreated EGFR exon 20 insertion+ metastatic NSCLC patients with/without prior anti-PD(L)-1 therapy Meeting Abstract


Authors: Janne, P.; Ramalingam, S.; Kim, T.; Yang, J. C.; Riely, G.; Mekhail, T.; Nguyen, D.; Campelo, M. R. G.; Felip, E.; Jin, S.; Griffin, C.; Bunn, V.; Lin, J.; Mehta, M.; Zhou, C.
Abstract Title: Mobocertinib in platinum-pretreated EGFR exon 20 insertion+ metastatic NSCLC patients with/without prior anti-PD(L)-1 therapy
Meeting Title: 2021 World Conference on Lung Cancer
Keywords: non-small cell lung cancer; insertion; egfr tyrosine kinase inhibitor; exon20
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 10 Suppl.
Meeting Dates: 2021 Sep 8-14
Meeting Location: Virtual event
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S960
Language: English
ACCESSION: WOS:000709606500235
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.08.235
Notes: Meeting Abstract: FP09.01 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely